Get everything you need to know about the Quest Laboratories IPO at IPOBase. Explore Quest Laboratories IPO details, including IPO dates, financial statements, valuation, peer comparison, and more.
Quest Laboratories Limited is a pharmaceutical company specializing in the manufacturing of a diverse range of pharmaceutical formulations. These formulations cover a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. Marketed under the trademark "Quest Laboratories Limited," these formulations cater to various medical needs and preferences, available in forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids.
Key Points:
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
Fields | Details |
---|---|
IPO Dates | 15 May - 17 May 2024 |
IPO Price Band | ₹ 93 - 97 per share |
Fresh Issue | 44,49,600 Shares |
Offer For Sale | NIL |
Total IPO Size | ₹ 43.16 crore |
Face Value | ₹ 10 |
Listing On | NSE |
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
Event | Date |
---|---|
IPO Opening Date | 15 May 2024 |
IPO Closing Date | 17 May 2024 |
Basis Of Allotment | 21 May 2024 |
Refunds | 22 May 2024 |
Demat Transfer | 22 May 2024 |
IPO Listing Date | 23 May 2024 |
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | Dec 2023 |
---|---|---|---|---|
Total Income | 30.44 | 59.54 | 61.87 | 62.18 |
Total Expenses | 29.65 | 53.78 | 54.91 | 51.03 |
Net Profit/Loss | 0.66 | 4.11 | 5.03 | 7.75 |
NPM (*) | 2.16 | 6.90 | 8.16 | 12.48 |
Total Assets | 18.40 | 34.80 | 46.65 | 58.69 |
Total Liabilities | 12.51 | 24.80 | 31.63 | 35.92 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | Dec 2023 |
---|---|---|---|---|
EPS | 0.61 | 3.81 | 4.66 | 7.18 |
ROE (%) | 11.78 | 51.69 | 40.20 | 34.03 |
ROCE (%) | 11.82 | 44.65 | 38.03 | 41.86 |
D/E Ratio | 0.52 | 0.31 | 0.27 | 0.20 |
Current Ratio | 1.10 | 1.17 | 1.25 | 1.42 |
EBITDA MARGIN (%) | 4.67 | 10.87 | 12.69 | 19.47 |
* Compiled from DRHP/RHP for valuation purposes.
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
Name | Revenue | P/E | EPS | RoNW | NAV |
---|---|---|---|---|---|
Quest Laboratories Limited | 61.64 | 20.82 | 4.66 | 33.47 | 13.93 |
Beta Drugs Limited | 157.87 | 66.43 | 19.57 | 19.55 | 100.12 |
Alpa Laboratories Limited | 92.96 | 15.92 | 5.90 | 8.59 | 68.69 |
Zenith Drugs Limited | 114.52 | 14.69 | 4.29 | 29.88 | 14.37 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
Investor Type | Subscribed |
---|---|
Qualified Institutional Buyer (QIB) | 57.2 |
Non-Institutional Investor (NII/HNI) | 184.1 |
Retail Individual Investor (RII) | 57.63 |
Total | 85.26 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
Bigshare Services Private Limited
Phone: +91 22-62638200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com
Quest Laboratories Limited
Plot No. 45, Sector III, Pithampur Industrial Area, Pithampur, Dhar - 454775, Madhya Pradesh, India.
Phone: + 91 7292292374
Email: investors@questlabltd.com
Website: www.questlabltd.com